Bausch Health Companies Inc. (BHC)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch BHC
Latest sale
$259k
Aug 19 · Routine
Form 4 sales
72
On record
Form 144 notices
6
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 144 noticeNotice
    Dec 2 2024

    Filed to sell 440 shares ($4k)

    Carson Seana, Officer

    10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 saleRoutine
    Dec 2 same day

    Sold 440 shares at $8.35 ($4k)

    Carson Seana, EVP, General Counsel

    10b5-1 planSold 0.1% of holdings ($3.6M position)433,066 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 4 saleNo plan
    Aug 21 +262 days

    Sold 15,912 shares at $7.66 ($122k)

    Lee Frank D., Director

    No 10b5-1 planSold 17.7% of holdings ($687k position)73,795 shares leftFirst sale on recordFiling

  4. 4 Form 4 saleUnusual
    Sep 8 +18 days

    Sold 13,370 shares at $7.31 ($98k)

    Carson Seana, EVP, General Counsel

    10b5-1 planSold 2.6% of holdings ($3.7M position)499,585 shares left30.4x usual sizeFiling

  5. 5 Form 4 saleRoutine
    Feb 27 +172 days

    Sold 8,388 shares at $5.95 ($50k)

    Carson Seana, EVP, General Counsel

    10b5-1 planSold 1% of holdings ($4.9M position)809,258 shares left0.9x usual sizeFiling

  6. 6 Form 4 saleRoutine
    Mar 3 +4 days

    Sold 11,276 shares at $5.78 ($65k)

    Carson Seana, EVP, General Counsel

    10b5-1 planSold 1.8% of holdings ($3.6M position)616,761 shares left1.3x usual sizeFiling

  7. 7 Form 4 saleRoutine
    May 19 +77 days

    Sold 24,456 shares at $5.43 ($133k)

    Lee Frank D., Director

    10b5-1 planSold 33.1% of holdings ($401k position)49,339 shares leftFiling

  8. 8 Form 4 saleRoutine
    Aug 19 +92 days

    Sold 36,827 shares at $7.03 ($259k)

    Lenar Aimee J., President, US Pharma

    10b5-1 planSold 9.9% of holdings ($2.6M position)334,853 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales, notices and lockups (78)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for BHC
Source
Aug 19, 2026Lenar Aimee J.President, US PharmaForm 4 sale36,827$259k9.9%RoutineSEC
May 19, 2026Lee Frank D.DirectorForm 4 sale24,456$133k33.1%RoutineSEC
Mar 3, 2026Carson SeanaEVP, General CounselForm 4 sale11,276$65k1.8%RoutineSEC
Feb 27, 2026Carson SeanaEVP, General CounselForm 4 sale8,388$50k1.0%RoutineSEC
Sep 8, 2025Carson SeanaEVP, General CounselForm 4 sale13,370$98k2.6%UnusualSEC
Aug 21, 2025Lee Frank D.DirectorForm 4 sale15,912$122k17.7%No planSEC
Dec 2, 2024Carson SeanaEVP, General CounselForm 4 sale440$4k0.1%RoutineSEC
Dec 2, 2024Carson SeanaOfficerForm 144 notice440$4kNoticeSEC
Sep 6, 2024Carson SeanaEVP, General CounselForm 4 sale13,370$83k3.0%UnusualSEC
Mar 4, 2024Carson SeanaEVP, General CounselForm 4 sale6,313$62k1.2%UnusualSEC
Mar 4, 2024Carson SeanaOfficerForm 144 notice6,313$62kNoticeSEC
Dec 5, 2023Carson SeanaEVP, General CounselForm 4 sale220$2k0.1%RoutineSEC
Dec 5, 2023Carson SeanaOfficerForm 144 notice220$2kNoticeSEC
Nov 6, 2023Carson SeanaEVP, General CounselForm 4 sale43$3270.0%RoutineSEC
Nov 6, 2023Carson SeanaOfficerForm 144 notice43$327NoticeSEC
Sep 6, 2023Carson SeanaEVP, General CounselForm 4 sale6,685$55k1.7%RoutineSEC
Sep 6, 2023Carson SeanaOfficerForm 144 notice6,685$55kNoticeSEC
Mar 6, 2023Carson SeanaOfficerForm 144 notice495$5kNoticeSEC
Feb 28, 2023Carson SeanaEVP, General CounselForm 4 sale292$3k0.1%Plan not statedSEC
Apr 14, 2022Spurr RobertU.S. President-Pharma BusinessForm 4 sale1,595$35k1.7%Plan not statedSEC
Mar 15, 2022Spurr RobertU.S. President-Pharma BusinessForm 4 sale4,846$108k5.0%Plan not statedSEC
Mar 8, 2022Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lForm 4 sale3,889$85k4.0%Plan not statedSEC
Mar 2, 2022Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lForm 4 sale11,077$259k9.9%Plan not statedSEC
Mar 2, 2022Spurr RobertU.S. President-Pharma BusinessForm 4 sale1,595$37k2.4%Plan not statedSEC
Mar 1, 2022Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lForm 4 sale6,338$151k5.3%Plan not statedSEC
Feb 15, 2022Spurr RobertU.S. President-Pharma BusinessForm 4 sale3,251$81k5.1%Plan not statedSEC
Jan 18, 2022Spurr RobertU.S. President-Pharma BusinessForm 4 sale3,251$87k4.9%Plan not statedSEC
Jun 11, 2021Eldessouky SamEVP & Chief Financial OfficerForm 4 sale17,000$539k12.7%Plan not statedSEC
Jun 2, 2021Ackermann ChristinaEVP AND GENERAL COUNSELForm 4 sale121,198$3.9M42.1%UnusualSEC
May 26, 2021Wechsler Amy BDirectorForm 4 sale11,037$351k10.1%Plan not statedSEC
Dec 4, 2020Humphries William D.President, Ortho-DermatologicsForm 4 sale114,055$2.3M32.7%UnusualSEC
Nov 27, 2020Humphries William D.President, Ortho-DermatologicsForm 4 sale36,804$722k13.5%Plan not statedSEC
Sep 8, 2020Humphries William D.President, Ortho-DermatologicsForm 4 sale5,667$92k2.4%Plan not statedSEC
Jun 5, 2020ValueAct Holdings II, L.P.DirectorForm 4 sale948,353$18.2M100.0%UnusualSEC
Aug 19, 2019McKenna Mark C.President, SalixForm 4 sale10,773$235k34.2%UnusualSEC
Aug 12, 2019Ackermann ChristinaEVP AND GENERAL COUNSELForm 4 sale3,418$77k6.3%Plan not statedSEC
Jul 11, 2019Ackermann ChristinaEVP AND GENERAL COUNSELForm 4 sale3,968$98k6.0%Plan not statedSEC
Oct 16, 2018Ackermann ChristinaEVP AND GENERAL COUNSELForm 4 sale19,946$498k27.9%UnusualSEC
Mar 6, 2018Paulson JohnDirectorForm 4 sale7.1M$109M33.9%UnusualSEC
Nov 16, 2017Paulson JohnDirectorForm 4 sale344,216$5M1.6%Plan not statedSEC
Mar 13, 2017PS Management GP, LLCDirectorForm 4 sale18.1M$199M100.0%UnusualSEC
Dec 12, 2016Pershing Square Capital Management, L.P.DirectorForm 4 sale3.5M$51.6M16.1%Plan not statedSEC
Nov 5, 2015Pearson J. MichaelChief Executive OfficerForm 4 sale1.3M$102M46.1%UnusualSEC
Jun 10, 2015ValueAct Capital Management, L.P.DirectorForm 4 sale4.2M$925M79.9%UnusualSEC
Jun 2, 2015Mirovsky PavelEVP, Pres. & GM Valeant EMENAForm 4 sale38,000$9M73.5%UnusualSEC
May 4, 2015Chai-Onn Robert RoswellEVP, CLO, General CounselForm 4 sale90,938$20.2M67.8%UnusualSEC
Mar 2, 2015Chai-Onn Robert RoswellEVP, CLO, General CounselForm 4 sale90,939$18.2M81.0%UnusualSEC
Jun 23, 2014Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.Form 4 sale10,203$1.2M29.8%UnusualSEC
Jun 2, 2014Mirovsky PavelPresident of Valeant EuropeForm 4 sale10,000$1.3M100.0%UnusualSEC
May 13, 2014Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.Form 4 sale10,000$1.3M29.4%UnusualSEC
Apr 1, 2014Provencio Norma AnnDirectorForm 4 sale5,000$661k3.5%Plan not statedSEC
Mar 17, 2014Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.Form 4 sale5,000$709k17.2%Plan not statedSEC
Mar 3, 2014Provencio Norma AnnDirectorForm 4 sale5,000$708k3.4%Plan not statedSEC
Feb 3, 2014Provencio Norma AnnDirectorForm 4 sale5,000$681k3.3%Plan not statedSEC
Jan 13, 2014Provencio Norma AnnDirectorForm 4 sale5,000$665k3.2%Plan not statedSEC
Nov 1, 2013Provencio Norma AnnDirectorForm 4 sale5,000$534k3.1%Plan not statedSEC
Sep 6, 2013Provencio Norma AnnDirectorForm 4 sale4,000$401k2.4%Plan not statedSEC
Sep 3, 2013Provencio Norma AnnDirectorForm 4 sale5,000$498k2.9%Plan not statedSEC
Jun 11, 2013Provencio Norma AnnDirectorForm 4 sale6,000$512k3.4%Plan not statedSEC
Nov 8, 2012De Silva RajivPres & COO, Specialty PharmForm 4 sale76,344$4.1M22.4%Plan not statedSEC
Nov 6, 2012De Silva RajivPres. & COO, Specialty PharmaForm 4 sale220,696$12M45.4%UnusualSEC
May 10, 2012Masterson Richard KevinPres. & COO, Valeant Intl. BBForm 4 sale4$2100.0%Plan not statedSEC
Mar 7, 2012Hall SusanGlobal Head of R&DForm 4 sale16,120$879k100.0%UnusualSEC
May 13, 2011VA Partners I, LLCDirectorForm 4 sale4.5M$225M23.0%Plan not statedSEC
May 11, 2011Durham Mark AndrewSVP Human ResourcesForm 4 sale50,000$2.6M44.8%UnusualSEC
Mar 10, 2011ValueAct Capital Management, L.P.DirectorForm 4 sale7.4M$275M27.3%UnusualSEC
Feb 28, 2011Ingram Robert AlexanderDirectorForm 4 sale9,872$395k100.0%UnusualSEC
Dec 7, 2010Wells William McDowallDirectorForm 4 sale507,851$14.3M87.1%UnusualSEC
Dec 1, 2010De Silva RajivPresident & COO Spec. Pharma.Form 4 sale219,897$5.9M43.0%UnusualSEC
Nov 29, 2010Chouinard MichelCOO, Biovail Labs.Intl SRLForm 4 sale134,908$3.4M98.2%UnusualSEC
Nov 9, 2010Chai-Onn Robert RoswellEVP, GC & Corp. Sec.Form 4 sale35,607$924k65.8%UnusualSEC
Nov 9, 2010Wells William McDowallDirectorForm 4 sale375,100$9.7M51.7%UnusualSEC
Aug 20, 2010Durham Mark AndrewSVP, HR & Shared ServicesForm 4 sale60,000$1.3M98.0%UnusualSEC
Aug 9, 2010Mayer ChristineSVP, BTA Pharmaceuticals, Inc.Form 4 sale20,000$458k100.0%UnusualSEC
Jun 1, 2010Squires Douglas John PaulDirectorForm 4 sale75,033$1.1M71.7%UnusualSEC
May 11, 2010Chouinard MichelCCO, Biovail Labs. Intl SRLForm 4 sale12,500$212k83.5%UnusualSEC
Mar 17, 2010Fibiger Hans ChristianChief Scientific OfficerForm 4 sale40,000$630k100.0%UnusualSEC
Mar 11, 2010Chouinard MichelCOO, Biovail Labs. Int'l SRLForm 4 sale21,829$337k89.8%UnusualSEC